Gaurav Shah - Net Worth and Insider Trading

Gaurav Shah Net Worth

The estimated net worth of Gaurav Shah is at least $23 Million dollars as of 2024-04-29. Gaurav Shah is the CEO of Rocket Pharmaceuticals Inc and owns about 1,027,577 shares of Rocket Pharmaceuticals Inc (RCKT) stock worth over $23 Million. Details can be seen in Gaurav Shah's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Gaurav Shah has not made any transactions after 2024-02-16 and currently still holds the listed stock(s).

Transaction Summary of Gaurav Shah

To

Gaurav Shah Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gaurav Shah owns 2 companies in total, including Rocket Pharmaceuticals Inc (RCKT) , and Talaris Therapeutics Inc (TALS) .

Click here to see the complete history of Gaurav Shah’s form 4 insider trades.

Insider Ownership Summary of Gaurav Shah

Ticker Comapny Transaction Date Type of Owner
RCKT Rocket Pharmaceuticals Inc 2024-02-16 director & See Remarks
TALS Talaris Therapeutics Inc 2021-05-06 director

Gaurav Shah Latest Holdings Summary

Gaurav Shah currently owns a total of 1 stock. Gaurav Shah owns 1,027,577 shares of Rocket Pharmaceuticals Inc (RCKT) as of February 16, 2024, with a value of $23 Million.

Latest Holdings of Gaurav Shah

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RCKT Rocket Pharmaceuticals Inc 2024-02-16 1,027,577 21.98 22,586,142

Holding Weightings of Gaurav Shah


Gaurav Shah Form 4 Trading Tracker

According to the SEC Form 4 filings, Gaurav Shah has made a total of 5 transactions in Rocket Pharmaceuticals Inc (RCKT) over the past 5 years, including 1 buys and 4 sells. The most-recent trade in Rocket Pharmaceuticals Inc is the sale of 20,272 shares on February 16, 2024, which brought Gaurav Shah around $604,916.

Insider Trading History of Gaurav Shah

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gaurav Shah Trading Performance

GuruFocus tracks the stock performance after each of Gaurav Shah's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gaurav Shah is -45.91%. GuruFocus also compares Gaurav Shah's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gaurav Shah within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Gaurav Shah's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Gaurav Shah

Average Return

20.21%

Average return per transaction

Outperforming Transactions

100%

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -15.17 -45.91 -10.93 20.21 28.64
Relative Return to S&P 500(%) -8.86 -37.87 -3.38 27.34 23.09

Gaurav Shah Ownership Network

Ownership Network List of Gaurav Shah

No Data

Ownership Network Relation of Gaurav Shah


Gaurav Shah Owned Company Details

What does Rocket Pharmaceuticals Inc do?

Who are the key executives at Rocket Pharmaceuticals Inc?

Gaurav Shah is the director & See Remarks of Rocket Pharmaceuticals Inc. Other key executives at Rocket Pharmaceuticals Inc include See Remarks John Militello , director & See Remarks David P Southwell , and Chief Medical Officer Mark Andrew White .

Rocket Pharmaceuticals Inc (RCKT) Insider Trades Summary

Over the past 18 months, Gaurav Shah made 4 insider transaction in Rocket Pharmaceuticals Inc (RCKT) with a net sale of 41,355. Other recent insider transactions involving Rocket Pharmaceuticals Inc (RCKT) include a net sale of 23,282 shares made by John Militello , a net sale of 308,989 shares made by Gotham Makker , and a net sale of 8,666 shares made by Kinnari Patel .

In summary, during the past 3 months, insiders sold 418,173 shares of Rocket Pharmaceuticals Inc (RCKT) in total and bought 0 shares, with a net sale of 418,173 shares. During the past 18 months, 486,057 shares of Rocket Pharmaceuticals Inc (RCKT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 486,057 shares.

Rocket Pharmaceuticals Inc (RCKT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Rocket Pharmaceuticals Inc Insider Transactions

No Available Data

Gaurav Shah Mailing Address

Above is the net worth, insider trading, and ownership report for Gaurav Shah. You might contact Gaurav Shah via mailing address: 430 East 29th Street, Suite 1040, New York Ny 10016.

Discussions on Gaurav Shah

No discussions yet.